サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1440037

妊活サプリメント - 世界市場の考察、競合情勢、市場予測（2030年）

Fertility Supplement - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
妊活サプリメント - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の妊活サプリメントの市場規模は、2022年に19億2,922万米ドル、2030年までに29億8,327万米ドルに達し、2024年～2030年の予測期間にCAGRで7.60％の成長を記録する可能性が高いです。妊活サプリメントの需要は主に、不妊症患者の増加、不妊症の原因となる危険因子の増加、リプロダクティブヘルスに対する意識の高まり、製品の発売の増加といった要因によって促進されており、それによって2024年～2030年の予測期間に市場はプラス成長を示す見込みです。

妊活サプリメントの市場力学

妊活サプリメント市場の成長に影響を与える主な要因の1つは、生殖年齢層における不妊症とその危険因子の有病率の上昇です。不妊症は世界中のカップルのかなりの割合を占めており、妊娠を望む声が不妊症関連の製品やサービスに対する需要を促進しています。

経済協力開発機構（OECD）（2023）が発表したデータによると、2021年の韓国、フランス、スウェーデン、スイスの合計特殊出生率（TFR）はそれぞれ0.81、1.80、1.67、1.51で、平均TFRの2.1を下回っています。

上記の資料によれば、2020年のTFRは、オーストラリアが1.58、カナダが1.50、中国が1.70、米国が1.64、英国が1.56、スペインが1.36、日本が1.33、韓国が0.84と、ほとんどの国が平均TFRを下回っています。

世界保健機関（WHO）（2023）の推計によると、世界の生殖年齢にある人の約6人に1人が生涯に不妊を経験するといいます。

世界銀行（2022）によると、北米、南米、欧州、アジア太平洋を含むほとんどの地域の2020年の合計特殊出生率（TFR）は1.6で、平均TFRの2.1よりの比較的低いです。

自然妊娠で困難に直面した人々は、ソリューションとして妊活サプリメントに頼ることが多いです。さらに、ライフスタイルの変化、キャリアの追求に起因する妊娠の遅れ、環境要因、飲酒、喫煙、運動不足、肥満などの複数の要因が、不妊率の上昇に寄与しています。

米国疾病予防管理センター（CDC）（2022）によると、2020年に、18歳以上の米国成人の100人中13人近くがタバコを吸っていました。Foundation for a Smoke-Free World（2022）が報告したデータによると、2019年のブラジルの成人喫煙者数は2,040万人でした。喫煙は男女ともに不妊を引き起こす主因の1つです。男性の精液の質に影響を与えるだけでなく、妊娠を望む女性にも合併症を引き起こします。

肥満は特に女性における生殖障害の発生と大きく関連しており、増加傾向にあります。肥満は、無排卵、月経障害、不妊症、生殖補助医療の困難、流産、妊娠転帰の悪化と関連しています。

OECD Health Statistics 2021によると、2019年にスイスの女性人口の約33％、イタリアの38.4％、スペインの42.7％の女性が肥満を含む過体重でした。

このように、男女の間で不妊症の罹患率が増加していることから、妊活サプリメントの需要が増加しており、2024年～2030年の予測期間に市場の成長を後押しすると予測されています。

しかし、規制監督と標準化の欠如や、体外受精のような市場での代替の選択肢の利用可能性が、妊活サプリメント市場の成長を抑制する可能性があります。

妊活サプリメント市場のセグメント分析

妊活サプリメント市場のエンドユーザーセグメントでは、2023年に女性が59.56%の最大のシェアを占めると予測されています。これは、女性不妊症のリスクの高まりと、女性不妊症の効果的な治療と管理における妊活サプリメントの役割が、予測期間の妊活サプリの需要増加の原因となっているためと考えられます。

女性不妊症には、年齢、ホルモンバランスの乱れ、体重、化学品や放射線への暴露、喫煙などの要因が関与しています。また、子宮頸管粘液の問題、子宮内膜症、卵管の損傷、多嚢胞性卵巣症候群（PCOS）、子宮筋腫などの女性の生殖器系障害も、女性の妊娠能力を妨げる可能性があります。

当レポートでは、世界の妊活サプリメント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 妊活サプリメント市場レポートのイントロダクション

第2章 妊活サプリメント市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 妊活サプリメント市場の主な要因の分析

  • 妊活サプリメント市場の促進要因
  • 妊活サプリメント市場の抑制要因と課題
  • 妊活サプリメント市場の機会

第5章 妊活サプリメント市場のポーターのファイブフォース分析

第6章 妊活サプリメント市場情勢

  • 成分別
    • 天然
    • 合成/天然と合成の混合
  • タイプ別
    • カプセル
    • 錠剤
    • ソフトジェル
    • 粉末
    • 液体
  • エンドユーザー別
    • 男性
    • 女性
  • 流通チャネル別
    • 小売薬局
    • オンライン薬局
    • その他
  • 地域
    • 北米の妊活サプリメントの市場規模（2021年～2030年）
    • 欧州の妊活サプリメントの市場規模（2021年～2030年）
    • アジア太平洋の妊活サプリメントの市場規模（2021年～2030年）
    • その他の地域の妊活サプリメントの市場規模（2021年～2030年）

第7章 妊活サプリメント市場の企業と製品のプロファイル

  • Fairhaven Health
  • Coast Science
  • LENUS Pharma GesmbH
  • Active Bio Life Science GmbH
  • Insud Pharma
  • Ovaterra
  • Vitabiotics Ltd
  • Orthomol Pharmazeutische Vertriebs GmbH
  • Snowden Healthcare
  • Crown Fertility
  • YadTech
  • Affirm Health Ltd.
  • BabyRx
  • Anglo-French Drugs & Industries Ltd.
  • Pillar Healthcare
  • Nua Fertility
  • Laboratories Fertypharm S.L.
  • Zacina
  • SAMSAR PHARMACEUTICALS SPRL
  • AdvaCare Pharma

第8章 KOLの見解

第9章 プロジェクトアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Fertility Supplements Market in Global (2021-2030)
  • Table 3: Fertility Supplements Market in Global by Ingredient Type (2021-2030)
  • Table 4: Fertility Supplements Market in Global by Type (2021-2030)
  • Table 5: Fertility Supplements Market in Global by End-User (2021-2030)
  • Table 6: Fertility Supplements Market in Global by Distribution Channel (2021-2030)
  • Table 7: Fertility Supplements Market in Global by Geography (2021-2030)
  • Table 8: Fertility Supplements Market in North America (2021-2030)
  • Table 9: Fertility Supplements Market in the US (2021-2030)
  • Table 10: Fertility Supplements Market in Canada (2021-2030)
  • Table 11: Fertility Supplements Market in Mexico (2021-2030)
  • Table 12: Fertility Supplements Market in Europe (2021-2030)
  • Table 13: Fertility Supplements Market in France (2021-2030)
  • Table 14: Fertility Supplements Market in Germany (2021-2030)
  • Table 15: Fertility Supplements Market in the United Kingdom (2021-2030)
  • Table 16: Fertility Supplements Market in Italy (2021-2030)
  • Table 17: Fertility Supplements Market in Spain (2021-2030)
  • Table 18: Fertility Supplements Market in the Rest of Europe (2021-2030)
  • Table 19: Fertility Supplements Market in Asia-Pacific (2021-2030)
  • Table 20: Fertility Supplements Market in China (2021-2030)
  • Table 21: Fertility Supplements Market in Japan (2021-2030)
  • Table 22: Fertility Supplements Market in India (2021-2030)
  • Table 23: Fertility Supplements Market in Australia (2021-2030)
  • Table 24: Fertility Supplements Market in South Korea (2021-2030)
  • Table 25: Fertility Supplements Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Fertility Supplements Market in the Rest of the World (2021-2030)
  • Table 27: Fertility Supplements Market in the Middle East (2021-2030)
  • Table 28: Fertility Supplements Market in Africa (2021-2030)
  • Table 29: Fertility Supplements Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Fertility Supplements Market in Global (2021-2030)
  • Figure 3: Fertility Supplements Market in Global by Ingredient Type (2021-2030)
  • Figure 4: Fertility Supplements Market in Global by Type (2021-2030)
  • Figure 5: Fertility Supplements Market in Global by End-User (2021-2030)
  • Figure 6: Fertility Supplements Market in Global by Distribution Channel (2021-2030)
  • Figure 7: Fertility Supplements Market in Global by Geography (2021-2030)
  • Figure 8: Fertility Supplements Market in North America (2021-2030)
  • Figure 9: Fertility Supplements Market in the US (2021-2030)
  • Figure 10: Fertility Supplements Market in Canada (2021-2030)
  • Figure 11: Fertility Supplements Market in Mexico (2021-2030)
  • Figure 12: Fertility Supplements Market in Europe (2021-2030)
  • Figure 13: Fertility Supplements Market in France (2021-2030)
  • Figure 14: Fertility Supplements Market in Germany (2021-2030)
  • Figure 15: Fertility Supplements Market in the United Kingdom (2021-2030)
  • Figure 16: Fertility Supplements Market in Italy (2021-2030)
  • Figure 17: Fertility Supplements Market in Spain (2021-2030)
  • Figure 18: Fertility Supplements Market in the Rest of Europe (2021-2030)
  • Figure 19: Fertility Supplements Market in Asia-Pacific (2021-2030)
  • Figure 20: Fertility Supplements Market in China (2021-2030)
  • Figure 21: Fertility Supplements Market in Japan (2021-2030)
  • Figure 22: Fertility Supplements Market in India (2021-2030)
  • Figure 23: Fertility Supplements Market in Australia (2021-2030)
  • Figure 24: Fertility Supplements Market in South Korea (2021-2030)
  • Figure 25: Fertility Supplements Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Fertility Supplements Market in the Rest of the World (2021-2030)
  • Figure 27: Fertility Supplements Market in the Middle East (2021-2030)
  • Figure 28: Fertility Supplements Market in Africa (2021-2030)
  • Figure 29: Fertility Supplements Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis
目次
Product Code: DISR0076

Fertility Supplements Market By Ingredient Type (Natural, Synthetic/Blend Of Sythetic And Natural), Type (Capsules, Tablets, Soft Gels, Powder, And Liquid) End-User (Men And Women), Distribution Channel (Retail Pharmacy, Online Pharmacy And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of infertility and the growing awareness on reproductive health

The global fertility supplements market was valued at USD 1,929.22 million in 2022 and is likely to register a CAGR of 7.60% during the forecast period from 2024 to 2030 to reach USD 2,983.27 million by 2030. The demand for fertility supplements is primarily being boosted owing to key factors such as the increasing number of cases of infertility, rise in risk factors associated with causing infertility, growing awareness on reproductive health coupled with increasing product launches thereby creating a positive market growth for fertility supplements during the forecast period from 2024-2030.

Fertility Supplements Market Dynamics:

One of the key factors influencing the growth of the fertility supplements market is the rising prevalence of infertility along with its risk factors among individuals in the reproductive age group. Infertility affects a significant percentage of couples worldwide, and the desire to conceive has fueled the demand for fertility-related products and services.

The data published by Organization for Economic Co-operation and Development (OECD) 2023 says that in 2021 the total fertility rate (TFR) in Korea, France, Sweden, and Switzerland was 0.81, 1.80, 1.67, and 1.51 respectively which is less than average TFR of 2.1.

As per the above mentioned source, the TFR for most of the countries in 2020 was below the average TFR with Australia having TFR of 1.58, Canada 1.50, China 1.70, United States 1.64, United Kingdom 1.56, Spain 1.36, Japan 1.33, and South Korea with 0.84 TFR.

The World Health Organization (WHO) 2023 estimates suggests that approximately one in every six people of reproductive age worldwide experience infertility in their lifetime.

According to World Bank 2022, the total fertility rate (TFR) in most of the regions including North and South America to Europe and Asia-Pacific was 1.6 in 2020 which is comparatively lower than the average TFR of 2.1.

As people face difficulties in conceiving naturally, they often turn to fertility supplements as a potential solution. In addition, several factors contribute to the rising infertility rates, including lifestyle changes, delayed pregnancies due to career pursuits, environmental factors, alcohol consumption, smoking, lack of physical activity, and obesity among others.

According to Centers for Disease Control and Prevention (CDC) 2022 , in 2020, nearly 13 of every 100 US adults aged 18 years or older smoked cigarettes. As per the data reported by Foundation for a Smoke-Free World 2022, there were 20.4 million adult smokers in Brazil in 2019. Smoking is one of the major factor responsible for causing infertility in both men and women. It not only affects semen quality in males but also creates complications for women who wish to conceive.

Obesity which is largely associated with causing reproductive disorders, particularly in women is on rise. It is associated with anovulation, menstrual disorders, infertility, difficulties in assisted reproduction, miscarriage, and adverse pregnancy outcomes.

As per OECD Health Statistics 2021, about 33% of women population of Switzerland, 38.4% in Italy, and 42.7% women in Spain were overweight including obesity in 2019.

Thus, the increasing incidences of infertility among men and women are increasing the demand for fertility supplements, which is anticipated to boost the market's growth over the forecast period from 2024-2030.

However, lack of regulatory oversight and standardization, availability of alternative options in the market such as in-vitro fertilization may restrict the growth of the fertility supplements market.

Fertility Supplements Market Segment Analysis:

Fertility Supplements Market by Ingredient Type (Natural, Synthetic/Blend of Synthetic and Natural), Type (Capsules, Tablets, Soft Gels, Powder and Liquid), End-User (Men and Women), Distribution Channel (Retail Pharmacy, Online Pharmacy, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the end-user segment of the fertility supplements market, women are expected to hold the largest share of 59.56% in the year 2023. This can be attributed to the growing risk of female infertility and role of fertility supplements in effective cure and management of female infertility which will be responsible for the increased demand of fertility supplements during the given forecast period.

The factors such as age, hormonal imbalances, weight, exposure to chemicals or radiation, and cigarette smoking contribute in female infertility. The female reproductive system disorders such as cervical mucus issues, endometriosis, damage to the fallopian tubes, polycystic ovary syndrome, (pcos), and uterine fibroids among others may also hinder the ability of women to conceive.

According to World Health Organization (WHO) 2021, roughly around 190 million (10%) women and girls of reproductive age get affected by endometriosis. As per OECD Health Statistics 2021, nearly more than 20% of the women population in countries like Hungary, Chile and France were involved in daily smoking in 2019. As per the same source 5% of women smoked daily in Indonesia, India, China, Costa Rica, Mexico and Korea in 2019. Smoking affects the female reproductive system and makes it difficult for women to conceive. Fertility supplements are crucial for the reproductive health of women. In order to produce the ideal conditions for a successful pregnancy, the intake of appropriate fertility supplements having composition of vitamin and mineral and other useful ingredients is essential.

The female fertility supplements may even help to lessen PCOS symptoms, a major underlying cause of infertility. PROFERTIL® female by LENUS Pharma GesmbH is female fertility supplement that increases the chance of having a baby. Also, the females prefer fertility supplements rather than visiting the doctor and opting for heavy dose of medicines.

Thus, the interplay of the above factors is expected to drive the growth of women category, thereby propelling the overall growth of fertility supplements market during the forecast period from 2023-2028.

North America is expected to dominate the overall Fertility Supplements Market:

Among all the regions, North America is expected to hold the largest share of 40.10% in the fertility supplements market in 2022. Some of the factors responsible for the growth of North America's fertility supplements market are the increasing prevalence of infertility in the region, increasing awareness for fertility supplements, and the presence of major players. Furthermore, increasing healthcare expenditure, rising research and development activities in the region associated with the surging launch of natural fertility supplements is also driving the market growth of fertility supplements in North America.

As per the data provided by the Centers for Disease Control and Prevention (CDC) 2023, in the United States, among married women aged 15 to 49 years with no prior births, about 1 in 5 (19%) are unable to get pregnant after one year of trying (infertility). Also, about 1 in 4 (26%) women have difficulty getting pregnant or carrying a pregnancy to term (impaired fecundity). About 6% of married women aged 15 to 49 years are unable to get pregnant after one year of trying and 14% have difficulty getting pregnant or carrying a pregnancy to term. In countries such as Canada, the fertility cases are quiet low. As per the Statistics Canada 2022, country's fertility rate decreased from 1.47 children per woman in 2019 to a record low of 1.40 children per woman in 2020.

Thus, the increasing infertility rate in the US and Canada will increase the demand for fertility supplements as these supplements aid in providing optimum amount of vitamins and hormones required for fertility in the body. Therefore, due to increase in the demand for fertility supplements in the region, there will subsequent rise in the growth of the North America fertility supplements market during the forecast period.

Fertility Supplements Market Key Players:

Some of the key market players operating in the Fertility Supplements market include Fairhaven Health, Coast Science, LENUS Pharma GesmbH, Active Bio Life Science GmbH, Insud Pharma, Ovaterra, Vitabiotics Ltd, Orthomol Pharmazeutische Vertriebs GmbH, Snowden Healthcare, Crown Fertility, YadTech, Affirm Health Ltd., BabyRx, Anglo-French Drugs & Industries Ltd., Pillar Healthcare, Nua Fertility, Laboratories Fertypharm S.L., Zacina, SAMSAR PHARMACEUTICALS SPRL, AdvaCare Pharma, and others.

Recent Developmental Activities in the Fertility Supplements Market:

In November 2022, AFD Pharma entered the fertility space in India with its Lyber range. The Lyber range includes 3 products namely, LYBER-M - a male fertility supplement; LYBER-PCO - a PCOS treatment drug and LYBER+ which is an herbal formulation of Shilajit and other power-packed phytomedicines which increases stamina, strength, energy and relieves stress.

In June 2022, the Natalist Company launched new products such as fertility supplements for every stage of the reproductive journey. The company launched consumer fertility, pregnancy, and essential postpartum products around 100% plastic neutral, including CoQ10 gummies, prenatal gummies, and other fertility and pregnancy test products.

In April 2022, the leading market player, Ovaterra, launched two prenatal vitamin supplement products, Advanced Prep 35-39 & Advanced Prenatal, designed for pre, during, and post-pregnancy care.

Key Takeaways from the Fertility Supplements Market Report Study

Market size analysis for current Fertility Supplements market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Fertility Supplements market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global Fertility Supplements market.

Various opportunities available for the other competitor in the Fertility Supplements market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current Fertility Supplements market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Fertility Supplements Market growth in the coming future?

Target Audience who can be benefited from this Fertility Supplements Market Report Study

Fertility Supplements products providers

Research organizations and consulting companies

Fertility Supplements-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Fertility Supplements

Various End-users who want to know more about the Fertility Supplements market and the latest technological developments in the Fertility Supplements market.

Frequently Asked Questions for the Fertility Supplements Market:

1. What are Fertility Supplements?

Fertility Supplements are dietary supplements designed to support reproductive health and improve fertility in both men and women. They are usually in the form of pills, capsules, soft gels, or liquid dietary supplements that are sold over the counter without a prescription and contain specific nutrients designed to support the quality of eggs, sperm, or other aspects of reproductive health.

2. What is the market for global Fertility Supplements?

The global fertility supplements market was valued at USD 1,929.22 million in 2022 and is likely to register a CAGR of 7.60% during the forecast period from 2024 to 2030 to reach USD 2,983.27 million by 2030.

3. What are the drivers for the global Fertility Supplements market?

The demand for fertility supplements is primarily being boosted owing to key factors such as the increasing number of cases of infertility, rise in risk factors associated with causing infertility, growing awareness on reproductive health coupled with increasing product launches thereby creating a positive market growth for fertility supplements during the forecast period from 2024-2030.

4. Who are the key players operating in the global Fertility Supplements market?

Some of the key market players operating in the Fertility Supplements market include Fairhaven Health, Coast Science, LENUS Pharma GesmbH, Active Bio Life Science GmbH, Insud Pharma, Ovaterra, Vitabiotics Ltd, Orthomol Pharmazeutische Vertriebs GmbH, Snowden Healthcare, Crown Fertility, YadTech, Affirm Health Ltd., BabyRx, Anglo-French Drugs & Industries Ltd., Pillar Healthcare, Nua Fertility, Laboratories Fertypharm S.L., Zacina, SAMSAR PHARMACEUTICALS SPRL, AdvaCare Pharma, and others.

5. Which region has the highest share in the Fertility Supplements market?

North America is expected to dominate the overall Fertility Supplements market during the forecast period from 2024-2030. Owing to factors such as the increasing prevalence of infertility in the region, increasing awareness for fertility supplements, and the presence of major players are expected to drive the demand for fertility supplements. Furthermore, increasing healthcare expenditure, rising research and development activities in the region associated with the surging launch of natural fertility supplements is also driving the market growth of fertility supplements in North America.

Table of Contents

1.Fertility Supplements Market Report Introduction

2. Fertility Supplements Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Fertility Supplements Market Key Factors Analysis

  • 4.1. Fertility Supplements Market Drivers
    • 4.1.1. Rising prevalence of infertility and its risk factors
    • 4.1.2. Rising awareness and focus on reproductive health
    • 4.1.3. Increased adoption of natural and holistic approaches
  • 4.2. Fertility Supplements Market Restraints and Challenges
    • 4.2.1. Lack of regulatory oversight and standardization
    • 4.2.2. Alternative options available in the market such as In-Vitro Fertilization (IVF)
  • 4.3. Fertility Supplements Market Opportunities
    • 4.3.1. Increasing Lucrative opportunities in the emerging markets and global expansion

5. Fertility Supplements Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Fertility Supplements Market Layout

  • 6.1. By Ingredient Type
    • 6.1.1. Natural
    • 6.1.2. Synthetic/Blend of Natural and Synthetic
  • 6.2. By Type
    • 6.2.1. Capsules
    • 6.2.2. Tablets
    • 6.2.3. Soft Gels
    • 6.2.4. Powder
    • 6.2.5. Liquid
  • 6.3. By End-User
    • 6.3.1. Men
    • 6.3.2. Women
  • 6.4. By Distribution Channel
    • 6.4.1. Retail Pharmacy
    • 6.4.2. Online Pharmacy
    • 6.4.3. Others
  • 6.5. By Geography
    • 6.5.1. North America Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.1.1. United States Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.1.2. Canada Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.1.3. Mexico Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.2. Europe Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.2.1. France Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.2.2. Germany Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.2.4. Italy Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.2.5. Spain Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.3. Asia-Pacific Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.3.1. China Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.3.2. Japan Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.3.3. India Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.3.4. Australia Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.3.5. South Korea Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Fertility Supplements Market Size in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW) Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.4.1. Middle East Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.4.2. Africa Fertility Supplements Market Size in USD million (2021-2030)
      • 6.5.4.3. South America Fertility Supplements Market Size in USD million (2021-2030)

7. Fertility Supplements Market Company and Product Profiles

  • 7.1. Fairhaven Health
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Coast Science
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. LENUS Pharma GesmbH
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Active Bio Life Science GmbH
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Insud Pharma
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Ovaterra
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Vitabiotics Ltd
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Orthomol Pharmazeutische Vertriebs GmbH
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Snowden Healthcare
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Crown Fertility
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. YadTech
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Affirm Health Ltd.
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. BabyRx
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Anglo-French Drugs & Industries Ltd.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Pillar Healthcare
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. Nua Fertility
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Laboratories Fertypharm S.L.
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. Zacina
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. SAMSAR PHARMACEUTICALS SPRL
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. AdvaCare Pharma
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us